Medicine and Dentistry
Surgery
100%
Liver Transplantation
92%
Cholangiocarcinoma
85%
Neoplasm
58%
Hepatectomy
45%
Malignant Neoplasm
37%
Pancreaticoduodenectomy
34%
Disease
32%
Overall Survival
29%
Pancreas Cancer
26%
Recurrent Disease
23%
Metastatic Carcinoma
22%
Pancreas Adenocarcinoma
21%
Bariatric Surgery
20%
Liver Graft
18%
Primary Sclerosing Cholangitis
16%
Hepatocellular Carcinoma
15%
Neoadjuvant Therapy
15%
Liver Metastasis
13%
Symptom
12%
Liver Disease
12%
Body Mass Index
11%
Cancer
11%
Neuroendocrine Tumor
11%
Transplantation
11%
Hepatocyte
11%
Chemoradiotherapy
11%
Hazard Ratio
11%
Surgeon
10%
Bleeding
10%
Distal Pancreatectomy
10%
Intraductal Papillary Mucinous Tumor
10%
Graft Survival
10%
Roux-en-Y Gastric Bypass
9%
Survival Rate
9%
Pancreatectomy
9%
Programmed Cell Death
9%
Magnetic Resonance Imaging
9%
Adenocarcinoma
8%
Lymph Node
8%
Bile Duct
8%
Neoadjuvant Chemotherapy
8%
Nonalcoholic Fatty Liver
8%
Microbiome
8%
Gut Microbiome
8%
Hepatitis C
8%
Quality of Life
7%
Infection
7%
Diabetes Mellitus
7%
Biopsy
7%
Odds Ratio
7%
Diagnosis
7%
Postoperative Complication
7%
Disease Free Survival
6%
Stomach Paresis
6%
Adjuvant Therapy
6%
Liver Cirrhosis
6%
Patient Referral
6%
Allograft
6%
Xenograft
6%
Colorectal Cancer
5%
Gastric Bypass Surgery
5%
Gastric Bypass
5%
Hepatic Portal Vein
5%
The Cancer Genome Atlas
5%
Ex Vivo
5%
Adjuvant Chemotherapy
5%
Pancreas Islet Cell Tumor
5%
Liver Failure
5%
Gut
5%
Proportional Hazards Model
5%
Long Term Survival
5%
Cholangiocyte
5%
Carcinoid
5%
Prevalence
5%
Interstitial Cell of Cajal
5%
Tyrosinemia
5%
Pancreatic Surgery
5%
Endoscopic Ultrasound
5%
Keyphrases
Liver Transplantation
71%
Cholangiocarcinoma
27%
Resection
23%
Transplantation
19%
Overall Survival
15%
Orthotopic Liver Transplantation
14%
Primary Sclerosing Cholangitis
14%
Liver
13%
Hilar Cholangiocarcinoma
12%
Pancreaticoduodenectomy
12%
Perihilar Cholangiocarcinoma
12%
Pancreatic Cancer
12%
Hepatocellular Carcinoma
12%
Tumor
12%
Mayo Clinic
11%
Hepatic Resection
10%
Neoadjuvant Therapy
9%
Risk Factors
8%
Pancreatic Ductal Adenocarcinoma
8%
Liver Resection
8%
Liver Transplant Recipients
8%
Patient Selection
8%
Surgical Resection
8%
Microbiome
8%
Neoadjuvant Chemoradiotherapy (nCRT)
7%
Operative
7%
Hazard Ratio
7%
Pretransplant
7%
5-year Survival
7%
MELD Score
7%
Patient Survival
7%
Bariatric Surgery
7%
Confidence Interval
7%
Clinical Outcomes
7%
Nonalcoholic Steatohepatitis
7%
Living Donor Liver Transplantation
6%
Graft Survival
6%
Carbohydrate Antigen 19-9 (CA19-9)
6%
Hepatitis C
6%
Interstitial Cells of Cajal
6%
Intraductal Papillary mucinous Neoplasm
5%
Postoperative Mortality
5%
Curative Resection
5%
Cholangiocarcinoma Cells
5%
Consecutive Patients
5%
Recurrence Rate
5%
Malignancy
5%
Neoadjuvant Chemotherapy
5%
Chemotherapy
5%
Metastasis
5%
Surgical Treatment
5%
Treatment Options
5%
Pancreas
5%